Uchil Rajesh R, Kohli Gurdeep Singh, Katekhaye Vijay M, Swami Onkar C
Consulting Physician, Department of Medicine, Holy Family Hospital , Bandra (W), Mumbai, India .
Director and Consultant Physician, Department of Medicine, Joy Nursing Home , Rajouri Garden, New Delhi, India .
J Clin Diagn Res. 2014 Jul;8(7):ME01-4. doi: 10.7860/JCDR/2014/8925.4529. Epub 2014 Jul 20.
The global burden of antimicrobial resistance is rising and is associated with increased morbidity and mortality in clinical and community setting. Spread of antibiotic resistance to different environmental niches and development of superbugs have further complicated the effective control strategies. International, national and local approaches have been advised for control and prevention of antimicrobial resistance. Rational use of antimicrobials, regulation on over-the-counter availability of antibiotics, improving hand hygiene and improving infection prevention and control are the major recommended approaches. Thorough understanding of resistance mechanism and innovation in new drugs and vaccines is the need. A multidisciplinary, collaborative, regulatory approach is demanded for combating antimicrobial resistance.
全球抗微生物药物耐药性负担正在上升,并与临床和社区环境中发病率和死亡率的增加相关。抗生素耐药性向不同环境生态位的传播以及超级细菌的出现,进一步使有效的控制策略变得复杂。已建议采取国际、国家和地方层面的方法来控制和预防抗微生物药物耐药性。合理使用抗微生物药物、规范抗生素非处方销售、改善手部卫生以及加强感染预防与控制是主要推荐方法。深入了解耐药机制以及研发新药和疫苗的创新至关重要。需要采取多学科、协作性的监管方法来对抗抗微生物药物耐药性。